News from NORD

Nominate a Colleague for a NORD 2017 Rare Impact Award


 

Continuing a 31-year tradition, the National Organization for Rare Disorders (NORD) will honor medical researchers, clinicians, patients, caregivers, and others who have had a positive impact on the rare disease community at its annual Rare Impact Awards celebration in May 2017. Nominations are now open and may be submitted online. Friday, Jan. 13, is the deadline for submitting nominations.

Nominees can include individuals or organizations. Past honorees have been recognized for their work in advocacy, research, patient care, awareness, ethics, and public policy. The 2017 honorees will be determined by a nominations committee comprised of NORD’s Scientific and Medical Advisory Committee, Board of Directors, and advocates.

The awards ceremony will take place on May 18 in the amphitheater of the Ronald Reagan Building and International Trade Center in Washington, DC. The 2017 Rare Impact Awards will continue NORD’s longstanding tradition of bringing together medical professionals, patients, caregivers, federal officials, and others to celebrate those who have had a positive impact on the community.

Recommended Reading

TSH antibody levels predict Graves relapse after thionamides
MDedge Endocrinology
Free Webinar Planned for Those Interested in Referring or Applying to NIH Undiagnosed Diseases Network
MDedge Endocrinology
NORD to Develop Natural History Studies With 20 Rare Disease Patient Organizations
MDedge Endocrinology
Patient Assistance Programs Fill Vital Need for Those With Rare Diseases
MDedge Endocrinology
$6.8 Million Awarded to Study the Biology of Rare and Undiagnosed Diseases
MDedge Endocrinology
Beloranib reduces weight in Prader-Willi syndrome, but concerns remain
MDedge Endocrinology
Adrenal gland tumors linked to ADHD diagnosis
MDedge Endocrinology
Enlist appropriate psychological consults for gender dysphoria
MDedge Endocrinology
Study identifies important predictors for PC/PGL
MDedge Endocrinology
European Commission’s proposed criteria for endocrine disruptors trigger multiple concerns
MDedge Endocrinology